Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota.
As a barrier, gut commensal microbiota can protect against potential pathogenic microbes in the gastrointestinal tract. Crosstalk between gut microbes and immune cells promotes human intestinal homeostasis. Dysbiosis of gut microbiota has been implicated in the development of many human metabolic disorders like obesity, hepatic steatohepatitis, and insulin resistance in type 2 diabetes (T2D). Certain microbes, such as butyrate-producing bacteria, are lower in T2D patients. The transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome, but the exact pathogenesis remains unclear. H. pylori in the human stomach cause chronic gastritis, peptic ulcers, and gastric cancers. H. pylori infection also induces insulin resistance and has been defined as a predisposing factor to T2D development. Gastric and fecal microbiota may have been changed in H. pylori-infected persons and mice to promote gastric inflammation and specific diseases. However, the interaction of H. pylori and gut microbiota in regulating host metabolism also remains unknown. Further studies aim to identify the H. pylori-microbiota-host metabolism axis and to test if H. pylori eradication or modification of gut microbiota can improve the control of human metabolic disorders.
Departments of Pediatrics, National Cheng Kung University Hospital, Medical College, National Cheng Kung University, #138 Sheng Li Road, Tainan 70428, Taiwan. yaojong@mail.ncku.edu.tw.|Institute of Clinical Medicine, Medical College, National Cheng Kung University, Tainan 70428, Taiwan. yaojong@mail.ncku.edu.tw.
Yao-Jong
YJ
Yang
Institute of Clinical Medicine, Medical College, National Cheng Kung University, Tainan 70428, Taiwan. sheubs@mail.ncku.edu.tw.|Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, #138 Sheng Li Road, Tainan 70428, Taiwan. sheubs@mail.ncku.edu.tw.
Bor-Shyang
BS
Sheu
H. pylori; diabetes; insulin resistant; metabolic interaction; microbiota
Gut. 2003 Jul;52(7):927-32
12801945
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):732-7
16407106
Helicobacter. 2008 Aug;13(4):234-8
18665930
Am J Gastroenterol. 2006 Jan;101(1):36-44
16405531
BMC Gastroenterol. 2014 Mar 19;14:49
24641276
JAMA. 2014 Nov 5;312(17):1772-8
25322359
Inflamm Bowel Dis. 2015 Apr;21(4):854-61
25742401
Helicobacter. 2011 Oct;16(5):389-97
21923685
Cell Host Microbe. 2015 May 13;17(5):662-71
25865369
J Appl Bacteriol. 1986 Mar;60(3):195-201
2423494
Nature. 2006 Dec 21;444(7122):1027-31
17183312
J Crohns Colitis. 2015 Dec;9(12):1088-95
26351391
Gastroenterology. 2012 Oct;143(4):913-6.e7
22728514
PLoS One. 2013 Oct 08;8(10):e76375
24116104
Lancet. 1984 Jun 16;1(8390):1311-5
6145023
Helicobacter. 2012 Dec;17(6):444-51
23066847
World J Gastroenterol. 2014 Jul 21;20(27):8979-85
25083071
Helicobacter. 2008 Apr;13(2):103-11
18321300
World J Gastroenterol. 2014 May 14;20(18):5226-34
24833852
World J Gastroenterol. 2014 Jun 7;20(21):6374-85
24914359
J Infect Dis. 2012 Apr 15;205(8):1195-202
22427676
Lancet. 1988 Dec 24-31;2(8626-8627):1437-42
2904568
ISME J. 2011 Apr;5(4):574-9
20927139
Annu Rev Nutr. 2002;22:283-307
12055347
World J Gastroenterol. 2012 Jun 7;18(21):2674-81
22690077
J Clin Microbiol. 2011 May;49(5):1987-9
21346040
Sci Rep. 2011;1:170
22355685
Am J Pathol. 1997 Mar;150(3):823-32
9060820
Gut Microbes. 2013 Nov-Dec;4(6):505-31
23962822
Ann Hematol. 2015 May;94(5):739-46
25501820
Nature. 2008 Oct 23;455(7216):1109-13
18806780
Science. 2014 Mar 28;343(6178):1249288
24625929
Inflamm Bowel Dis. 2010 Jun;16(6):1077-84
19760778
Anaerobe. 2011 Dec;17(6):478-82
21497661
Gastroenterology. 2006 Aug;131(2):525-37
16890606
BMJ. 2014 May 20;348:g3174
24846275
PLoS One. 2013 Jul 04;8(7):e68833
23861946
J Gastroenterol. 2012 Dec;47(12):1298-307
22576027
Helicobacter. 2012 Aug;17(4):297-304
22759330
Front Microbiol. 2011 Jan 20;1:148
21687748
Arab J Gastroenterol. 2013 Jun;14(2):55-8
23820501
Nature. 2012 Oct 4;490(7418):55-60
23023125
Pediatr Infect Dis J. 2014 Dec;33(12):1277-82
25389709
Gastroenterology. 2012 Mar;142(3):490-6
22155369
Gut. 2011 Nov;60(11):1479-86
21471567
J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):249-56
19271298
Helicobacter. 2012 Sep;17 Suppl 1:56-61
22958157
Science. 2011 Jan 21;331(6015):337-41
21205640
Science. 2011 May 20;332(6032):974-7
21512004
Eur J Clin Invest. 2013 Sep;43(9):949-56
23879740
Gut. 2014 Sep;63(9):1513-21
24833634
Gastroenterology. 2009 Jan;136(1):65-80
19026645
Heart. 1996 Jun;75(6):573-5
8697159
J Atheroscler Thromb. 2010 Oct 27;17(10):1041-8
20610892
Ann Nutr Metab. 2013;63 Suppl 2:8-15
24217032
Early Hum Dev. 2010 Jul;86 Suppl 1:13-5
20133091
Nat Immunol. 2010 Jan;11(1):28-35
20016507
Best Pract Res Clin Gastroenterol. 2014 Dec;28(6):995-1002
25439066
J Gastroenterol. 2015 Oct;50(10):1027-40
25689935
Gastroenterology. 2015 Jul;149(1):102-109.e6
25857665
Microbiome. 2013 May 10;1(1):15
24450737
Gut. 1993 Mar;34(3):386-91
8386131
South Med J. 2002 Aug;95(8):842-5
12190218
FEMS Microbiol Lett. 2002 Dec 17;217(2):133-9
12480096
IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
7715068
Nat Rev Microbiol. 2008 Feb;6(2):121-31
18180751
Am J Gastroenterol. 2015 Jun;110(6):921-30
25986361
Pediatrics. 2006 Aug;118(2):511-21
16882802
PLoS One. 2014 Jun 18;9(6):e100362
24941045
Cell. 2009 Oct 30;139(3):485-98
19836068
Lipids Health Dis. 2009 Dec 23;8:59
20030806
Sci Rep. 2015 Mar 04;5:8731
25736205
Inflamm Bowel Dis. 2011 Jun;17(6):1398-408
21560200